Backyard gene editing risks creating a monster
By Editorial,
New Scientist
| 03. 15. 2017
The gene-editing revolution continues to gather pace, but it is also throwing us curveballs. One is an unexpected technical hitch (see “Mosaic problem stands in the way of gene editing embryos“). Another concerns oversight and ownership: who gets to use it, and for what?
In January, David Ishee, a dog breeder from Mississippi, told the US Food and Drug Administration that he planned to use CRISPR gene editing to fix a mutation that makes Dalmatians prone to kidney disease (see “How dogs are helping decode the genetic roots of personality“).
The FDA responded by telling Ishee that he could experiment, but not sell or even give away his modified dogs. The law was recently amended so that gene-edited animals require approval before they can be sold.
But the FDA also said it would reconsider if presented with evidence that certain types of gene editing pose “minimal risk”. How that will be defined or decided is not clear, but it means we could soon see a cottage industry of gene-edited animals created in biohackers’ sheds.
At first glance...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Peter de Kruijff, ABC News | 09.16.2025
Do you wonder where your meat comes from? Maybe it is organic, wild harvested, or farmed.
Or perhaps it was designed in a lab.
Faster-growing fish, heat-tolerant cows and disease-resistant pigs are among a new class of animals that are...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
By Staff, GMWatch | 08.10.2025
Protesting Against Monsanto and GMOs
by William Murphy, CC2.0
GMWatch has published a series of interviews with the late scientist Dr Arpad Pusztai, conducted in March 2002 by the journalist Andy Rowell, as part of his research for his book, Don't...